Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| microglial cell | 10 studies | 24% ± 9% | |
| astrocyte | 7 studies | 25% ± 7% | |
| macrophage | 5 studies | 33% ± 12% | |
| oligodendrocyte precursor cell | 4 studies | 17% ± 2% | |
| glutamatergic neuron | 4 studies | 52% ± 21% | |
| classical monocyte | 3 studies | 23% ± 7% | |
| hematopoietic precursor cell | 3 studies | 27% ± 7% | |
| endothelial cell | 3 studies | 29% ± 10% | |
| myeloid cell | 3 studies | 28% ± 6% | |
| epithelial cell | 3 studies | 22% ± 7% | |
| GABAergic neuron | 3 studies | 43% ± 11% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 6% | |
| monocyte | 3 studies | 23% ± 6% | |
| transit amplifying cell | 3 studies | 27% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 743.80 | 1439 / 1445 | 100% | 21.91 | 183 / 183 |
| bladder | 100% | 982.52 | 21 / 21 | 99% | 28.96 | 501 / 504 |
| lung | 100% | 1122.12 | 576 / 578 | 100% | 21.41 | 1151 / 1155 |
| intestine | 100% | 869.57 | 964 / 966 | 99% | 18.87 | 524 / 527 |
| breast | 100% | 879.91 | 458 / 459 | 99% | 22.92 | 1105 / 1118 |
| skin | 99% | 975.40 | 1794 / 1809 | 99% | 32.23 | 469 / 472 |
| thymus | 100% | 1402.78 | 653 / 653 | 99% | 17.69 | 596 / 605 |
| kidney | 100% | 880.24 | 89 / 89 | 96% | 10.98 | 868 / 901 |
| uterus | 94% | 557.33 | 160 / 170 | 99% | 20.85 | 454 / 459 |
| stomach | 93% | 515.79 | 333 / 359 | 99% | 17.93 | 284 / 286 |
| prostate | 98% | 681.47 | 241 / 245 | 92% | 9.75 | 461 / 502 |
| brain | 87% | 790.77 | 2293 / 2642 | 100% | 19.47 | 702 / 705 |
| adrenal gland | 100% | 1051.96 | 258 / 258 | 75% | 6.67 | 172 / 230 |
| ovary | 67% | 272.31 | 121 / 180 | 99% | 19.47 | 427 / 430 |
| liver | 82% | 419.53 | 185 / 226 | 72% | 8.43 | 291 / 406 |
| pancreas | 49% | 165.32 | 162 / 328 | 96% | 14.47 | 170 / 178 |
| adipose | 100% | 1090.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 17.82 | 29 / 29 |
| muscle | 100% | 1273.59 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1806.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 16.45 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.40 | 1 / 1 |
| blood vessel | 100% | 1594.34 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 19.87 | 78 / 80 |
| peripheral blood | 96% | 1517.89 | 889 / 929 | 0% | 0 | 0 / 0 |
| heart | 94% | 633.89 | 809 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1905461 | Biological process | positive regulation of vascular associated smooth muscle cell apoptotic process |
| GO_0070345 | Biological process | negative regulation of fat cell proliferation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0006606 | Biological process | protein import into nucleus |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
| GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0001216 | Molecular function | DNA-binding transcription activator activity |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | E2F3 |
| Protein name | Transcription factor E2F3 (E2F-3) E2F transcription factor 3 isoform d E2F transcription factor 3 isoform c E2F3 protein |
| Synonyms | KIAA0075 |
| Description | FUNCTION: Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F3 binds specifically to RB1 in a cell-cycle dependent manner. Inhibits adipogenesis, probably through the repression of CEBPA binding to its target gene promoters (By similarity). . |
| Accessions | A0A3S9X9Y1 ENST00000535432.2 [O00716-2] Q24JQ3 Q499G5 ENST00000346618.8 [O00716-1] A0A3Q9JIX6 O00716 |